Alpine Associates Management’s Immunomedics Inc IMMU Stock Holding History

Alpine Associates Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,414,515	Closed	-$120M	–	52
2020 Q3	$120M	Buy	+1,414,515	New	+$71.5M	6.32%	5

Alpine Associates Management's IMMU Position: Q4 2020 in Review

Alpine Associates Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,414,515 shares — an estimated $120M sold.

Alpine Associates Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $120M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Alpine Associates Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Alpine Associates Management sold 1,414,515 Immunomedics Inc shares in Q4 2020, an estimated $120M.
Alpine Associates Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Alpine Associates Management's Immunomedics Inc position peaked at $120M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Alpine Associates Management's 13F filing for Q4 2020, filed 10 Feb 2021.